Related Articles
CRITERIA FOR ASSESSING THE NEUROENDOCRINE PHENOTYPE AND ITS INCIDENCE IN NONSMALL CELL LUNG CANCERS
Management of neuroendocrine carcinomas of the breast: A rare entity
Low apoptotic activity in primary prostate carcinomas without response to hormonal therapy.
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells
Solid neuroendocrine breast carcinomas: Incidence, clinico-pathological features and immunohistochemical profiling